Larfix Dosage/Direction for Use

Dosage: For all patients the appropriate dosing regimen should be based upon individual response to treatment.
Acute pain: 8-16 mg lornoxicam daily divided into 2 or 3 doses. Maximum recommended daily dose is 16 mg.
Osteoarthritis and rheumatoid arthritis: Initial recommended dose is 12 mg lornoxicam daily divided into 2 or 3 doses.
Maintenance dose should not exceed 16 mg lornoxicam daily.
Additional information on special populations: Children and adolescents: Lornoxicam is not recommended for use in children and adolescents below age 18 because of a lack of data on safety and efficacy.
Elderly: No special dosage modification is required for elderly patients above age 65 unless renal or hepatic function is impaired. Lornoxicam should be administered with precaution as gastrointestinal adverse effects are less well tolerated in this group.
Renal impairment: For patients with mild to moderate renal impairment the maximum recommended daily dose is 12 mg divided in 2 or 3 doses.
Hepatic impairment: For patients with moderate hepatic impairment the maximum recommended daily dose is 12 mg divided in 2 or 3 doses.
Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms.
Method of administration: Larfix are supplied for oral administration and should be taken with a sufficient quantity of liquid.